These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911 [TBL] [Abstract][Full Text] [Related]
6. Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis. Czaja AJ; Ludwig J; Baggenstoss AH; Wolf A N Engl J Med; 1981 Jan; 304(1):5-9. PubMed ID: 7432437 [TBL] [Abstract][Full Text] [Related]
7. [The histological picture of chronic-aggressive hepatitis in immunosuppressive therapy]. Förster E; Maas D; Beck K; Oehlert W; Birnbaum F Dtsch Med Wochenschr; 1971 Jan; 96(1):1-5. PubMed ID: 5312887 [No Abstract] [Full Text] [Related]
8. Chronic hepatitis; prognostic aspects. Fehér J; Jakab L; Süle I; Szilvási I; Józsa L Acta Med Acad Sci Hung; 1976; 33(4):299-307. PubMed ID: 1032237 [TBL] [Abstract][Full Text] [Related]
9. [Long-term results of immunosuppressive treatment of chronic aggressive hepatitis (author's transl)]. Gottesmann T; Moeschlin S Dtsch Med Wochenschr; 1978 Dec; 103(50):1989-93. PubMed ID: 720235 [TBL] [Abstract][Full Text] [Related]
10. [Histological criteria for evaluation of the prognosis of chronic hepatitis]. Oancea R; Serbănescu M; Lazăr V; Corduban T Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(6):511-20. PubMed ID: 2871609 [No Abstract] [Full Text] [Related]
11. Chronic persistent hepatitis. A clinical, serological, and prognostic study. Dietrichson O Scand J Gastroenterol; 1975; 10(3):249-55. PubMed ID: 1138326 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic evaluation of chronic aggressive nepatitis and its relation to the Australian antigen. Jorge AD; Sanchez D Acta Hepatogastroenterol (Stuttg); 1978 Jun; 25(3):179-84. PubMed ID: 665118 [TBL] [Abstract][Full Text] [Related]
13. [Long term therapy of chronic progressive (aggressive) hepatitis using a combination of imuran and prednisone]. Schimmelpfennig W; Wagner K; Theuer D; Schneider G; Hecht A; Schimmelpfennig R Dtsch Gesundheitsw; 1971 Oct; 26(42):1965-71. PubMed ID: 5004132 [No Abstract] [Full Text] [Related]
15. [Immunosuppressive long-term treatment of chronic aggressive hepatitis]. Schimmelpfennig W; Schneider G; Wagner K; Wack R; Lunzenauer K Z Gesamte Inn Med; 1975 Dec; 30(24):273 concl. PubMed ID: 1221650 [TBL] [Abstract][Full Text] [Related]
16. Peritoneoscopy in chronic hepatitis. A retrospective evaluation of its role in the management of the asymptomatic patient. Mazzacca G; Bianco AR; Vecchione R; Piai G; Capalbo G; Budillon G Am J Gastroenterol; 1980 Sep; 74(3):244-50. PubMed ID: 6451170 [TBL] [Abstract][Full Text] [Related]
17. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II]. Ohlen I; Liegl JM; Selmair H Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215 [TBL] [Abstract][Full Text] [Related]
18. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases. Shen K; Yu Y; Tang Z; Liu Z; Li L Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205 [TBL] [Abstract][Full Text] [Related]
19. Morphologic evolution of CAH with and without therapy. A two year follow-up. Celle G; Volpi C; Testa R; Dodero M Hepatogastroenterology; 1980 Aug; 27(4):283-5. PubMed ID: 7203364 [TBL] [Abstract][Full Text] [Related]
20. [Dynamics of chronic active hepatitis with varying degrees of severity]. Serov VV; Aprosina ZG; Popov MS; Popova IV; Tikhonova GN Arkh Patol; 1981; 43(8):12-27. PubMed ID: 6457594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]